Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre

Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway

(2020) Eli Marie Grindedal et al.   Familial Cancer

The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients

(2020) M. Gleeson et al.   GYNECOLOGIC ONCOLOGY

Moving into the mainstream: healthcare professionals’ views of implementing treatment focussed genetic testing in breast cancer care

(2019) Nina Hallowell et al.   Familial Cancer

Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer

(2019) Erin Tutty et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

(2018) Andrew Tutt et al.   NATURE MEDICINE

Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and/or ovarian) cancer susceptibility genes: An international survey by the Enigma Clinical Working Group.

(2018) Sarah Nielsen et al.   JOURNAL OF CLINICAL ONCOLOGY

Medicare-funded cancer genetic tests: a note of caution

(2018) Judy Kirk et al.   MEDICAL JOURNAL OF AUSTRALIA

Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics

(2017) Maira Kentwell et al.   GYNECOLOGIC ONCOLOGY

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

(2017) Mark Robson et al.   NEW ENGLAND JOURNAL OF MEDICINE

“I'm Healthy, It's Not Going To Be Me”: Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia

(2016) Catherine A. Beard et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Mastering genomic terminology

(2016) Gail P. Jarvik et al.   GENETICS IN MEDICINE

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

(2016) Angela George et al.   Scientific Reports

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface

(2013) A J Lee et al.   BRITISH JOURNAL OF CANCER

The Angelina Jolie effect

(2013) Paul A James et al.   MEDICAL JOURNAL OF AUSTRALIA

ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes

(2011) Amanda B. Spurdle et al.   HUMAN MUTATION

Radio-induced malignancies after breast cancer post-operative radiotherapy in patients with Li- Fraumeni syndrome

(2010) Steve Heymann et al.   Radiation Oncology

Survival Analysis of Cancer Risk Reduction Strategies forBRCA1/2Mutation Carriers

(2009) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

(2008) Sharon E. Plon et al.   HUMAN MUTATION